Trade Mark Journal No.2026/012 20 March 2026

UK00004348561 3 March 2026 (5)

Mark 1

Image for mark UK00004348561_1of4 RE-AIM THERAPEUTICS

Mark 2

Image for mark UK00004348561_2of4

Mark 3

Image for mark UK00004348561_3of4

Mark 4

Image for mark UK00004348561_4of4
Class 5
Pharmaceuticals; therapeutics; pharmaceuticals and therapeutics for the treatment of autoimmune diseases; pharmaceuticals and therapeutics for the treatment of inflammatory diseases and conditions; pharmaceuticals and therapeutics for the treatment of irritable bowel disease, metabolic disorders, psoriasis, psoriatic arthritis, hidradenitis suppurativa and ankylosing spondylitis.

Re-Aim Therapeutics Ltd

Representative: Kilburn & Strode LLP